[Results of treatment and adrenal cortex function in patients with bronchial asthma after long-term use of depot betamethasone].
D000302:Adrenal Cortex / Q000187:drug effects*; D000309:Adrenal Insufficiency / Q000139:chemically induced; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D001993:Bronchodilator Agents; D004338:Drug Combinations; C032812:betamethasone dipropionate, betamethasone sodium phosphate drug combination; D001623:Betamethasone
Wyniki leczenia i czynność kory nadnerczy chorych na astme oskrzelowa leczonych przewlekle betametazonem typu depot.